WRIGHT MEDICAL GROUP N.V.: 10-Q filed 2016-11-02
What WRIGHT MEDICAL GROUP N.V. reported in its quarterly report filed 2016-11-02 (fiscal Q3 2016): 40 published measures, 110 facts as tagged in accession 0001492658-16-000039.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-02
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001492658-16-000039 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WRIGHT MEDICAL GROUP N.V. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 2,316,326,000 | USD | |
| At 2015-12-27 | 2,073,494,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 1,571,221,000 | USD | |
| At 2015-12-27 | 1,018,468,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 745,105,000 | USD | |
| At 2015-12-27 | 1,055,026,000 | USD | |
| At 2015-09-30 | 113,971,000 | USD | |
| At 2014-12-31 | 278,803,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -110,145,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | -387,503,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | -98,861,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -192,924,000 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | -25,353,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | -141,839,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | 37,800,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | 34,013,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | 241,464,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | 207,219,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | -42,561,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | -36,434,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | -1,161,369,000 | USD | |
| At 2015-12-27 | -773,866,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 103,072,000 | shares | 91 |
| 2015-12-28 to 2016-09-25 | 102,854,000 | shares | 273 |
| 2015-07-01 to 2015-09-30 | 52,750,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 52,607,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 103,072,000 | shares | 91 |
| 2015-12-28 to 2016-09-25 | 102,854,000 | shares | 273 |
| 2015-07-01 to 2015-09-30 | 52,750,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 52,607,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -1.07 | USD/shares | 91 |
| 2015-12-28 to 2016-09-25 | -3.77 | USD/shares | 273 |
| 2015-07-01 to 2015-09-30 | -1.87 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -3.67 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -1.07 | USD/shares | 91 |
| 2015-12-28 to 2016-09-25 | -3.77 | USD/shares | 273 |
| 2015-07-01 to 2015-09-30 | -1.87 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -3.67 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -2,325,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | -6,913,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 187,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 511,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 211,096,000 | USD | |
| At 2015-12-27 | 224,256,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -38,604,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | -103,666,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | -41,042,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -108,505,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 739,434,000 | USD | |
| At 2015-12-27 | 559,884,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 431,332,000 | USD | |
| At 2015-12-27 | 206,938,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 25,181,000 | USD | |
| At 2015-12-27 | 30,904,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 855,800,000 | USD | |
| At 2015-12-27 | 866,989,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 121,794,000 | USD | |
| At 2015-12-27 | 131,050,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 149,787,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 459,181,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 98,129,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 283,186,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 170,819,000 | USD | |
| At 2015-12-27 | 210,701,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 111,183,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 355,515,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 57,087,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 174,681,000 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 129,840,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 401,069,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 85,997,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 250,801,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 12,481,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 36,705,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 9,570,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 24,644,000 | USD | 273 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 1,901,386,000 | USD | |
| At 2015-12-27 | 1,835,586,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 1,279,000 | USD | |
| At 2015-12-27 | -10,484,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 364,034,000 | USD | |
| At 2015-12-27 | 331,416,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 152,938,000 | USD | |
| At 2015-12-27 | 107,160,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 247,771,000 | USD | |
| At 2015-12-27 | 250,928,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 259,448,000 | USD | |
| At 2015-12-27 | 137,174,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 341,945,000 | USD | |
| At 2015-12-27 | 208,574,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-25 | 399,985,000 | USD | |
| At 2015-12-27 | 171,171,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | -105,665,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | -375,740,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | -100,442,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -200,217,000 | USD | 273 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 7,466,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 21,407,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | 2,562,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 7,741,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-06-27 to 2016-09-25 | 365,000 | USD | 91 |
| 2015-12-28 to 2016-09-25 | 3,494,000 | USD | 273 |
| 2015-07-01 to 2015-09-30 | -10,236,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -7,395,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | -9,900,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | -2,878,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | 3,662,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | 33,779,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-12-28 to 2016-09-25 | -6,659,000 | USD | 273 |
| 2015-01-01 to 2015-09-30 | 1,866,000 | USD | 273 |
Inspect the source
- Entity
- WRIGHT MEDICAL GROUP N.V. / CIK 0001492658
- Captured
- SEC response SHA-256
50d81e3caed503df71e41bc7927a9bbc4a7e1e2f375b8d33fbf0679bcddf4058
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001492658.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))